PT  - JOURNAL ARTICLE
ED  - ,
TI  - Erratum: <em>Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort</em>
AID  - 10.1136/gutjnl-2016-312444corr1
DP  - 2016 Dec 01
TA  - Gut
PG  - 2060--2060
VI  - 65
IP  - 12
4099  - http://gut.bmj.com/content/65/12/2060.short
4100  - http://gut.bmj.com/content/65/12/2060.full
SO  - Gut2016 Dec 01; 65